908-359-8980 Menu

Improving the health of our patients through groundbreaking clinical research

The Schweiger Dermatology Group (SDG) Clinical Research Department Research Clinic is led by Dr. David Goldberg, founder of Skin, Laser and Surgery Specialist of New York and New Jersey. Dr. Goldberg brings more than 25 years of experience in conducting large multi-center clinical trials on a wide variety of cosmetic and medical devices, as well as pharmaceutical treatments. Our research team is committed to responsible research conducted under strict industry and safety standards.

Current Clinical Trials:

Study: Evaluation of Non-Treatment Mind.Px Patch for Plaque Psoriasis

Purpose: The purpose of this investigation is to evaluate the impact of Mind.Px on response to biologic treatment for Plaque Psoriasis. This is not meant to treat plaque psoriasis, but to inform the physician on the likelihood for a patient to respond to one or more biologic treatments.

Qualifications:

  • Males and females, ages 18 or older
  • Medical diagnosis of plaque psoriasis

Duration: Approximately 16 weeks

Location: Hackensack, NJ

Compensation: Up to $630

Interested in participating in our clinical research study? Please click here.


Study: Efficacy and Safety study of RPT193 as Monotherapy in Adults with Moderate-to-Severe Atopic Dermatitis

Purpose: This study is being done to evaluate the safety and tolerability of RPT193 in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in adult patients who have had an inadequate response to topical medications for AD (e.g., corticosteroids) or who are otherwise unable to take topical medications.

Qualifications:

  • Male and Females, 18 to 75 years old
  • Clinical diagnosis of Atopic Dermatitis
  • Documented history of inadequate response to a ≥1 month treatment with topical medications

Duration: Up to 7 months

Location: Hackensack, NJ

Compensation: Up to $650

Interested in participating in our clinical research study? Please click here.


Study: Efficacy, Safety, and Tolerability of Rocatinlimab (AMG 451) in Combination With Topical Corticosteroids and/or Topical Calcineurin Inhibitors in Adult Subjects With Moderate-to-Severe Atopic Dermatitis

Purpose: This study is being done to evaluate the safety and tolerability of Rocatinlimab (AMG 451) in subjects with moderate to severe atopic dermatitis, also known as eczema. Investigational product will be administered as monotherapy for AD in combination with topical corticosteroids/topical calcineurin inhibitor. This is a placebo-controlled, double-blind study.

Qualifications:

  • Males and Females, ages 18 or older
  • Clinical diagnosis of Atopic Dermatitis
  • Documented history of inadequate response to topical corticosteroids within 6 months

Duration: Approximately 6 months

Location: Hackensack, NJ

Compensation: $30 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Study: Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate-to-Severe Pruritus in Adult Subjects with Atopic Dermatitis

Purpose: This study is being done to evaluate to evaluate the efficacy of 2 dose levels of oral difelikefalin as adjunct therapy to a topical corticosteroid (TCS), compared to placebo and to TCS alone, in reducing the intensity of itch after 12 weeks of treatment for moderate-to-severe pruritus in adult subjects with atopic dermatitis (AD).

Qualifications:

  • Males and Females, between 18 – 80 years of age
  • Clinical diagnosis of active Atopic Dermatitis
  • Chronic pruritus related to Atopic Dermatitis

Duration: Approximately 4 months

Location: Hackensack, NJ

Compensation: $68 per visit will be paid to the patient *once all visits are completed*

Interested in participating in our clinical research study? Please click here.


Interested in participating in our clinical research study? Please click here.

What to expect during a clinical trial:

  • Access to new investigational treatments before they are made widely available
  • Financial compensation for participation
  • An opportunity to contribute to the advancement of medical science through research
  • Study visits conducted by a trained and dedicated research team
  • Adherence to strict industry and safety standards.
  • Evaluations performed by one of our certified provide

To learn more contact: Diana Aranzazu, [email protected], 609-219-5621

Schedule A Consultation

Contact Us

Skin Laser & Surgery Specials of NY & NJ is now a division of Schweiger Dermatology Group.

Practice Policy Update Regarding COVID-19

The health and safety of our patients and staff is our top priority. Our in-office safety policies are aligned with the latest guidelines issued by the CDC and local government officials related to COVID-19.

New safety policies for patients:

  • Patients will undergo screening questions and receive comprehensive instructions about our new policies prior to their appointment.
  • To minimize contact, we will offer patients virtual check in and check out.
  • Patients will be instructed to come to the office wearing a mask.
  • Patient temperatures will be checked via forehead scanners upon arrival to the office.
  • We have reorganized our offices to maximize social distancing and cleanliness, and we have altered workflows to allow patients to wait outside or in their cars until their exam room is ready. Patients will be contacted via text message or phone call when the provider is ready for the visit to begin.
  • We are asking for patients to arrive at their appointment alone. For children and adult patients who require a caretaker, one adult may accompany the patient.
  • Patients who are sick or have had exposures to COVID-19 will be rescheduled.
  • Offices will be cleaned and disinfected frequently throughout the day.
  • Teledermatology appointments remain available for patients who prefer to be seen virtually.

New safety policies for office & staff:

  • All of our staff have completed training on all new workflows and infection prevention measures.
  • All of our clinical staff will be wearing appropriate personal protective equipment (PPE) during patient encounters to include masks and eye protection.
  • Our exam rooms are sanitized before and after every patient visit.
  • All SLSS team members will be screened for symptoms and/or fever daily prior to coming to work.
BOOK NOW
Contact Us